Compare
United Guardian Inc vs cbdMD, Inc. vs Axil Brands, Inc. vs DSwiss Inc
| Latest fiscal year | United Guardian Inc UG | cbdMD, Inc. YCBD | Axil Brands, Inc. AXIL | DSwiss Inc DQWS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-09-30 | 2026-05-31 | 2025-12-31 |
| Revenue | $10.55M | $19.19M | $30.85M | $2.92M |
| Revenue growth (YoY) | -13.4% | -1.5% | +17.5% | -6.2% |
| Gross margin | 48.8% (computed) | 62.4% | 69.3% | 19.3% |
| Operating margin | 21.3% | -11.3% | 9.7% | 0.0% |
| Net margin | 20.0% | -10.6% | 8.8% | -2.6% |
| Net income | $2.11M | -$2.04M | $2.70M | -$76.9K |
| EPS (Diluted) | n/a | -$1.09 | $0.33 | $0.00 |
| Operating cash flow | $1.97M | -$1.45M | -$9.6K | -$94.3K |
| Free cash flow | $1.91M | -$1.64M | -$89.0K | -$135.3K |
| Cash & equivalents | $1.25M | $2.26M | $4.46M | $285.0K |
| Total assets | $13.11M | $10.42M | $17.96M | $677.1K |
| Total liabilities | $1.88M | $3.19M | $4.81M | $686.5K |
| Shareholders' equity | $11.23M | $7.23M | $13.14M | -$9.3K |
| Return on year-end equity | 18.7% | -28.2% | 20.5% | n/a |
| Shares outstanding | 4.59M | 8.92M | 6.82M | 206.90M |
Revenue, most recent five fiscal years
| Fiscal year | United Guardian Inc | cbdMD, Inc. | Axil Brands, Inc. | DSwiss Inc |
|---|---|---|---|---|
| Latest | $10.55M Ended 2025-12-31 | $19.19M Ended 2025-09-30 | $30.85M Ended 2026-05-31 | $2.92M Ended 2025-12-31 |
| 1 year earlier | $12.18M Ended 2024-12-31 | $19.48M Ended 2024-09-30 | $26.26M Ended 2025-05-31 | $3.11M Ended 2024-12-31 |
| 2 years earlier | $10.89M Ended 2023-12-31 | $24.16M Ended 2023-09-30 | $27.50M Ended 2024-05-31 | $1.47M Ended 2023-12-31 |
| 3 years earlier | $12.70M Ended 2022-12-31 | $35.40M Ended 2022-09-30 | $23.52M Ended 2023-05-31 | $1.85M Ended 2022-12-31 |
| 4 years earlier | $13.93M Ended 2021-12-31 | $44.48M Ended 2021-09-30 | $2.34M Ended 2022-05-31 | $1.96M Ended 2021-12-31 |